Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
71 Cards in this Set
- Front
- Back
chlorthalidone
|
thiazide like
|
|
metolazone
|
thiazide like
|
|
indapamide
|
thiazide like
|
|
acetazolamide
|
CA inhibitor
|
|
dorzolamide
|
CA inhibitor
|
|
brinzolamide
|
CA inhibitor
|
|
CA inhibitor inhibit....and enhance.....
|
bicarb and Na reabsorption, enhance phosphate excretion
|
|
what to use for glaucoma
|
dorzolamide of brinzolamide
|
|
drug for mountain sickness
|
CA inhibitor
|
|
drug for metabolic alkalosis
|
CA inhibitor
|
|
furosemide
|
loop diuretic
|
|
bumetanide
|
loop diuretic
|
|
torsemide
|
loop diuretic
|
|
ethacrynic acid
|
loop diuretic
|
|
MOA of loop diuretic
|
inhibits NKCC2
|
|
which loop diuretic possess CA inhibition activity
|
furosemide
|
|
triamterene
|
K sparing inhibitor of ENaC
|
|
amiloride
|
K sparing inhibitor of ENaC
|
|
spironolactone
|
K sparing aldosterone antagonist
|
|
eplerenone
|
K sparing aldosterone antagonist
|
|
Nesiritide
|
Natriuretic Peptide (human recombinant BNP)
|
|
Carperitidie
|
human recombinant ANP
|
|
mannitol
|
aquaretic-osmotic diuretic
|
|
urea
|
aquaretic osmotic diuretic
|
|
glycerin
|
aquaretic osmotic diuretic
|
|
isosorbide
|
aquaretic osmotic diuretic
|
|
conivaptan
|
aquaretic vasopressin antagonist
|
|
tolvaptan
|
aquaretic vasopressin antagonist
|
|
lithium
|
aquaretic vasopressin antagonist
|
|
demeclocycline
|
aquaretic vasopressin antagonist
|
|
where do thiazides work
|
DCT
|
|
3 things Thiazides do
|
inhibit NCC (NaCl) reabsorption
enhances Ca reabsorption d/t low Na in cell that activates Na/Ca exchange on basolateral side enhanced prostaglandin production |
|
tx of CHF
|
thiazide
|
|
tx of hypercalciuria
|
thiazide
|
|
tx of nephrogenic diabetes insipidus
|
thiazide
|
|
tx of nephrogenic diabetes insipidus
|
thiazides
|
|
adverse effects of thiazides
|
hypokalemic metabolic acidosis
hyponatremia hyperglycemia, hyperlipidemia hyper urecemia, hypercacemia, (hyperGLUC) sulfa sensitivity hyper |
|
secondary effect of K sparing ENaC inhibitors
|
decreased excretion of K and H due to hyperpolarization of cell
|
|
drugs that increase prostaglandin production
|
loop diuretics, thiazides, K sparing
|
|
indication for k sparing diuretic ENaC inhibitor
|
tx of htn with other drugs
|
|
liddle syndrome and tx for it
|
autosomal dominant form of low-renin htn due ot mutations in ENaC; tx is k sparing diuretic
|
|
adverse effects of k sparing ENaC inhibitors
|
hyperkalemia (K not excreted b/c Na isn't reabsorbed) (esp inpts taking meds that reduce RAS activity)
metabolic acidosis (H not excreted) *triamterene can cause megaloblastic anemia, interstitial nephritis, kidney stones |
|
site of action of k sparing
|
Collecting Duct
|
|
MOA of aldosterone antagonists
|
competitive antagonist of aldosterone receptor in collecting duct; inhibits H and K secretion
|
|
indications for K sparing aldosterone antagonist
|
hyperaldosteronism, K depletion, CHF
|
|
eplerenone is tx for what?
|
HTN only
|
|
adverse effects of aldosterone antagonists
|
hyperkalemia
metabolic acidosis endocrine effects w/ spirnolactone |
|
common adverse effects for all k sparing
|
hyperkalemia and metabolic acidosis
|
|
gynecosmastia in males or deepening of voice in females is adverse effect of which drug
|
spironolactone
|
|
MOA of natriuretic peptides
|
binds to receptors in Collecting duct that stimulate cGMP
cGMP inhibits the non selective cation channel CNGC PKG is also stimulated which inhibits Na pump activity os Na is not reabsorbed |
|
what else do natriuretic peptides do
|
inhibit renin release,
inhibit endothelin secretion vasodilate decreases systemic sympathetic activity |
|
indicated for pts with acute decompensated heart failure
|
nesiritide
|
|
reduces preload (venular dilation)
reduces afterload (arteriolar dilation) increases natriuresis |
both nesiritide and carperitide
|
|
MOA of osmotic diuretics
|
draw water into lumen with it
|
|
where are osmotic diuretics working
|
PCT and descending limb
|
|
osmotic diuretics used for
|
drug detox, elevated intracranial/intraocular pressure, prophylaxis for acute renal failure
|
|
adverse effects of osmotic diuretics
|
pulm edema
dehydration contraindicated in CHF pts |
|
vasopressin antagonists of V1a and V2 receptors
|
conivaptan
|
|
oral form vasopressin antagonist
|
tolvaptan
|
|
antagonst at v2 receptor only
|
tolvaptan
|
|
action of v1a V1b receptors
|
contraction of vascular smooth muscle and contraction of myometrium
|
|
action of V2 receptors
|
bring aquaporin 2 channels to luminal membrane
|
|
action of lithium and demeclocycline
|
decrease formation of or interfere with action of cAMP
|
|
use of vasopressin antagonists
|
CHF, SIADH
|
|
adverse effect of megaloblastic anemia or interstitial nephritis
|
triamterene
|
|
clinical indications for thiazides
|
hypercalciuria, CHF, hypertension, nephrogenic diabetes insipidius
|
|
drugs that cause alkalemia
|
loop and thiazides
|
|
drugs that cause acidemia
|
CA inhibitors, K sparing
|
|
increases Ca in urine
|
loop diuretics
|
|
decreases Ca in urine
|
thiazides
|
|
loop adverse effects
|
OHDANG
ototoxicity, hypokalemia, dehydration, allergy, nephritis (interstitial), gout |